SCHEMBL6713314

SCHEMBL6713314

CCCCCCCC/C=C/CCCCCCCCCC(=O)Cl

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.75
TSHR P16473 1/20 0.75
TERT O14746 3/20 0.68
PTPN1 P18031 3/20 0.68
PPARG P37231 3/20 0.68
PPARD Q03181 3/20 0.68
PPARA Q07869 3/20 0.68
FAAH O00519 3/20 0.68
CYP1A2 P05177 2/20 0.68
MAPT P10636 2/20 0.68
CYP2C19 P33261 2/20 0.68
BLM P54132 2/20 0.68
HSD17B10 Q99714 2/20 0.68
FABP4 P15090 2/20 0.68
KMT2A Q03164 2/20 0.68
GMNN O75496 1/20 0.68
USP2 O75604 1/20 0.68
LMNA P02545 1/20 0.68
POLB P06746 1/20 0.68
CYP2C9 P11712 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15500041 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL1114784 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL3228812 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL3123425 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL1114787 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL22230778 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL5478764 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL7243894 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL22230779 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG
SCHEMBL11060705 1.00 ALDH1A1 (0.75) ALDH1A1TSHRTERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762175-B2 LIPOPHILIC BIOLOGICALLY ACTIVE COMPOUND CONTAINING IN ITS MOLECULAR STRUCTURE ONE OR MORE FUNCTIONAL GROUPS SELECTED FROM ALCOHOL, ETHER, PHENYL, AMINO, AMIDO, THIOL, ACID AND ESTER IN WHICH ONE GROUP IS REPLACED BY LIPOPHILIC GROUP NORSK HYDRO ASA (NO) 2004-07-13 US disclosed
EP-0977725-B1 NEW FATTY ACID DERIVATIVES CONPHARMA AS (NO) 2004-06-16 EP disclosed
US-20040063677-A1 Methods of treating disorders using lipophilic derivatives NORSK HYDRO ASA 2004-04-01 US disclosed
US-20030153544-A1 Lipophilic biologically active compound containing in its molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, acid and ester in which one group is replaced by lipophilic group CONPHARMA AS (NO) 2003-08-14 US disclosed
US-6548486-B1 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid NORSK HYDRO A.S. (NO) 2003-04-15 US disclosed
EP-1015479-A4 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR LILLY CO ELI (US) 2002-07-24 EP disclosed
US-20010006962-A1 FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 2001-07-05 US disclosed
EP-1015479-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 2000-07-05 EP disclosed
EP-0977725-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 2000-02-09 EP disclosed
EP-0973936-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC AMINOTHIOETHER ACIDS ELI LILLY AND COMPANY (US) 2000-01-26 EP disclosed
WO-1998046631-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 1998-10-22 WO disclosed
WO-1998032718-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 1998-07-30 WO disclosed
EP-0825164-A2 Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1997026300-A1 COMBINATORIAL PROCESS FOR PREPARING SUBSTITUTED INDANE LIBRARIES ELI LILLY AND COMPANY (US) 1997-07-24 WO disclosed
EP-0642525-A1 CHEMICAL COMPOUNDS. NORSK HYDRO AS (NO) 1995-03-15 EP disclosed
US-5223627-A Using a 4-nitro-2,1,3-benzoxadiazole compound ABBOTT LABORATORIES (US) 1993-06-29 US disclosed
EP-0253271-B1 FLUORESCENCE POLARIZATION METHOD FOR MONITORING FETAL LUNG MATURITY ABBOTT LABORATORIES (US) 1993-06-02 EP disclosed
WO-1993007163-A1 CHEMICAL COMPOUNDS NORSK HYDRO A.S. (NO) 1993-04-15 WO disclosed
US-4784961-A NITROAMINO BENZOXADIAZOLE DERIVATIVE FLUORESCENT COMPOUNDS ABBOTT LABORATORIES (US) 1988-11-15 US disclosed
EP-0253271-A1 Fluorescence polarization method for monitoring fetal lung maturity ABBOTT LABORATORIES (US) 1988-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010006962-A1 FATTY ACID DERIVATIVES HADH, NR1H2, NR1H3 ALDH1A1 684/4885TSHR 467/4885TERT 2430/4885
US-20040063677-A1 Methods of treating disorders using lipophilic derivatives NCEH1, NR1H2, NR1H3 ALDH1A1 1118/4885TSHR 321/4885TERT 1935/4885
US-20030153544-A1 Lipophilic biologically active compound containing in its molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, acid and ester in which one group is replaced by lipophilic group TSPO, NR1H2, NR1H3 ALDH1A1 640/4885TSHR 161/4885TERT 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.